Terms: = Ovarian cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src
268 results:
1. Emerging Roles of YES1 in cancer: The Putative Target in Drug Resistance.
Kook E; Chun KS; Kim DH
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338729
[TBL] [Abstract] [Full Text] [Related]
2. Compartment-specific multiomic profiling identifies src and GNAS as candidate drivers of epithelial-to-mesenchymal transition in ovarian carcinosarcoma.
Herrington CS; Oswald AJ; Stillie LJ; Croy I; Churchman M; Hollis RL
Br J Cancer; 2024 Feb; 130(2):327-335. PubMed ID: 38097740
[TBL] [Abstract] [Full Text] [Related]
3. MET overexpression in ovarian cancer via CD24-induced downregulation of miR-181a: A signalling for cellular quiescence-like state and chemoresistance in ovarian CSCs.
Kwon JE; Jang Y; Yun BS; Kang S; Kim YH; Kim BG; Cho NH
Cell Prolif; 2024 May; 57(5):e13582. PubMed ID: 38030594
[TBL] [Abstract] [Full Text] [Related]
4. Hypoxia-associated genetic signature in ovarian steroid cell tumor NOS.
Chao A; Huang HJ; Lin CY; Lee CH; Lin CH; Chao AS; Lai CH; Chang TC; Wu KY; Wu RC
Endocr Relat Cancer; 2023 Nov; 30(11):. PubMed ID: 37655726
[TBL] [Abstract] [Full Text] [Related]
5. Starvation-inactivated MTOR triggers cell migration via a ULK1-SH3PXD2A/TKS5-MMP14 pathway in ovarian carcinoma.
Lin CY; Wu KY; Chi LM; Tang YH; Huang HJ; Lai CH; Tsai CN; Tsai CL
Autophagy; 2023 Dec; 19(12):3151-3168. PubMed ID: 37505094
[TBL] [Abstract] [Full Text] [Related]
6. Preliminary outcomes of five-year survival for ovarian malignancies in profiled Serbian Oncology Centre.
Gutic B; Bozanovic T; Mandic A; Dugalic S; Todorovic J; Dugalic MG; Sengul D; Detanac DA; Sengul I; Detanac D; Kesicioglu T; Soares Junior JM
Clinics (Sao Paulo); 2023; 78():100204. PubMed ID: 37148829
[TBL] [Abstract] [Full Text] [Related]
7. Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR.
Chien W; Tyner JW; Gery S; Zheng Y; Li LY; Gopinatha Pillai MS; Nam C; Bhowmick NA; Lin DC; Koeffler HP
J Ovarian Res; 2023 Apr; 16(1):80. PubMed ID: 37087441
[TBL] [Abstract] [Full Text] [Related]
8. ROS-mediated SRMS activation confers platinum resistance in ovarian cancer.
Jiang Y; Song L; Lin Y; Nowialis P; Gao Q; Li T; Li B; Mao X; Song Q; Xing C; Zheng G; Huang S; Jin L
Oncogene; 2023 May; 42(20):1672-1684. PubMed ID: 37020040
[TBL] [Abstract] [Full Text] [Related]
9. ALKBH5 activates FAK signaling through m6A demethylation in
Sun R; Yuan L; Jiang Y; Wan Y; Ma X; Yang J; Sun G; Zhou S; Wang H; Qiu J; Zhang L; Cheng W
Theranostics; 2023; 13(2):833-848. PubMed ID: 36632222
[No Abstract] [Full Text] [Related]
10. src-3/TRAF4 facilitates ovarian cancer development by activating the PI3K/AKT signaling pathway.
Wang Y; Luo X; Wu N; Liao Q; Wang J
Med Oncol; 2023 Jan; 40(2):76. PubMed ID: 36625999
[TBL] [Abstract] [Full Text] [Related]
11. Developing and Testing Methylated Nano-Structured Dipeptides that Inhibit src Kinase Activity In Vitro for Anti-cancer Applications.
Nahhas AF; Nahhas AF; Webster TJ
J Vis Exp; 2022 Nov; (189):. PubMed ID: 36533825
[TBL] [Abstract] [Full Text] [Related]
12. Novel Approaches for the Solid-Phase Synthesis of Dihydroquinazoline-2(1
Wang Q; Pan Y; Luo H; Zhang Y; Gao F; Wang J; Zheng J
Molecules; 2022 Dec; 27(23):. PubMed ID: 36500678
[TBL] [Abstract] [Full Text] [Related]
13. CUB Domain-Containing Protein 1 (CDCP1) is a rational target for the development of imaging tracers and antibody-drug conjugates for cancer detection and therapy.
Khan T; Lyons NJ; Gough M; Kwah KKX; Cuda TJ; Snell CE; Tse BW; Sokolowski KA; Pearce LA; Adams TE; Rose SE; Puttick S; Pajic M; Adams MN; He Y; Hooper JD; Kryza T
Theranostics; 2022; 12(16):6915-6930. PubMed ID: 36276654
[No Abstract] [Full Text] [Related]
14. Polarity switching of ovarian cancer cell clusters via src family kinase is involved in the peritoneal dissemination.
Kawata M; Kondo J; Onuma K; Ito Y; Yokoi T; Hamanishi J; Mandai M; Kimura T; Inoue M
Cancer Sci; 2022 Oct; 113(10):3437-3448. PubMed ID: 35848881
[TBL] [Abstract] [Full Text] [Related]
15. Methylated DNA markers for plasma detection of ovarian cancer: Discovery, validation, and clinical feasibility.
Marinelli LM; Kisiel JB; Slettedahl SW; Mahoney DW; Lemens MA; Shridhar V; Taylor WR; Staub JK; Cao X; Foote PH; Burger KN; Berger CK; O'Connell MC; Doering KA; Giakoumopoulos M; Berg H; Volkmann C; Solsrud A; Allawi HT; Kaiser M; Vaccaro AM; Albright Crawford C; Moehlenkamp C; Shea G; Deist MS; Schoolmeester JK; Kerr SE; Sherman ME; Bakkum-Gamez JN
Gynecol Oncol; 2022 Jun; 165(3):568-576. PubMed ID: 35370009
[TBL] [Abstract] [Full Text] [Related]
16. 2-Hydroxyestradiol Overcomes Mesenchymal Stem Cells-Mediated Platinum Chemoresistance in ovarian cancer Cells in an ERK-Independent Fashion.
Khamaisi H; Mahmoud H; Mahajna J
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164068
[TBL] [Abstract] [Full Text] [Related]
17. Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis.
Zhang J; Li Y; Liu H; Zhang J; Wang J; Xia J; Zhang Y; Yu X; Ma J; Huang M; Wang J; Wang L; Li Q; Cui R; Yang W; Xu Y; Feng W
J Exp Clin Cancer Res; 2022 Jan; 41(1):24. PubMed ID: 35033172
[TBL] [Abstract] [Full Text] [Related]
18. L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/src/STAT3 signaling.
Giordano M; Decio A; Battistini C; Baronio M; Bianchi F; Villa A; Bertalot G; Freddi S; Lupia M; Jodice MG; Ubezio P; Colombo N; Giavazzi R; Cavallaro U
J Exp Clin Cancer Res; 2021 Oct; 40(1):319. PubMed ID: 34645505
[TBL] [Abstract] [Full Text] [Related]
19. TAGLN mediated stiffness-regulated ovarian cancer progression via RhoA/ROCK pathway.
Wei X; Lou H; Zhou D; Jia Y; Li H; Huang Q; Ma J; Yang Z; Sun C; Meng Y; Xu S; Yang X; Li X; Ji T; Guo Z; Gao Q
J Exp Clin Cancer Res; 2021 Sep; 40(1):292. PubMed ID: 34538264
[TBL] [Abstract] [Full Text] [Related]
20. MiR-192-5p inhibits proliferation, migration, and invasion in papillary thyroid carcinoma cells by regulation of SH3RF3.
Fu S; Ma C; Tang X; Ma X; Jing G; Zhao N; Ran J
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34486645
[TBL] [Abstract] [Full Text] [Related]
[Next]
